Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PHASE-III' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 879 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rodriguez-Nieto, MJ; Peces-Barba, G; Mangado, NG; Verbanck, S; Paiva, M
      Single-breath washouts in a rotating stretcher

      JOURNAL OF APPLIED PHYSIOLOGY
    2. Sondak, VK
      Adjuvant therapy for melanoma

      CANCER JOURNAL
    3. Psyrri, A; Murren, J
      Small cell lung cancer: Strategies to optimize chemotherapy response

      CANCER JOURNAL
    4. Diedrich, K; Ludwig, M; Felberbaum, RE
      The role of gonadotropin-releasing hormone antagonists in in vitro fertilization

      SEMINARS IN REPRODUCTIVE MEDICINE
    5. Buchner, T; Hiddemann, W; Schoch, C; Haferlach, T; Sauerland, MC; Heinecke, A
      Acute myeloid leukaemia (AML): treatment of the older patient

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    6. Estey, EH
      Growth factors in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    7. Agarwala, SS; Sabbagh, MH
      Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironment

      EXPERT OPINION ON BIOLOGICAL THERAPY
    8. Johnston, SRD
      Systemic treatment of metastatic breast cancer

      HOSPITAL MEDICINE
    9. Chodak, GW; Kolvenbag, GJCM
      Will the experience with tamoxifen in breast cancer help define the role of antiandrogens in prostate cancer?

      PROSTATE CANCER AND PROSTATIC DISEASES
    10. Tester, W; Mora, J
      Innovative treatments for advanced non-small cell lung cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    11. Buzdar, A; Howell, A
      Advances in aromatase inhibition: Clinical efficacy and tolerability in the treatment of breast cancer

      CLINICAL CANCER RESEARCH
    12. Hayes, DF; Yamauchi, H; Broadwater, G; Cirrincione, CT; Rodrigue, SP; Berry, DA; Younger, J; Panasci, LL; Millard, F; Duggan, DB; Norton, L; Henderson, IC
      Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and leukemia group B study 8662

      CLINICAL CANCER RESEARCH
    13. Cairo, MS
      Myelopoietic growth factors after stem cell transplantation: Does it pay

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    14. Holdsworth, MT; Mathew, P
      Efficacy of colony-stimulating factors in acute leukemia

      ANNALS OF PHARMACOTHERAPY
    15. Finley, RS
      Colony-stimulating factors in acute leukemia: will we ever have an answer?

      ANNALS OF PHARMACOTHERAPY
    16. Luck, HJ; Du Bois, A; Weber, B; Pfisterer, J; Goupil, A; Kuhn, W; Barats, JC; Blohmer, J; Mousseau, M; Schroder, W; Meier, W; Mobus, V; Richter, B
      The integration of anthracyclines in the treatment of advanced ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    17. Thurnher, D; Bakroeva, M; Formanek, M; Knerer, B; Kornfehl, J
      Non-steroidal anti-inflammatory drugs inhibit telomerase activity in head and neck squamous carcinoma cell lines

      HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    18. Hartmann, F; Jacobs, G; Gotto, H; Schwamborn, J; Pfreundschuh, M
      Cytosine arabinoside, idarubicin and divided dose etoposide for the treatment of acute myeloid leukemia in elderly patients

      LEUKEMIA & LYMPHOMA
    19. Jourdan, E; Reiffers, J; Stoppa, AM; Sotto, JJ; Attal, M; Bouabdallaha, R; Marit, G; Fegueux, N; Boulat, O; Dastugue, N; Boiron, JM; Faberes, C; Gastaut, JA; Maraninchi, D; Blaise, D
      Outcome of adult patients with acute myeloid leukemia who failed to achieve complete remission after one course of induction chemotherapy: a report from the BGMT study group

      LEUKEMIA & LYMPHOMA
    20. Gaspar, LE
      Optimizing chemoradiation therapy approaches to unresectable stage III non-small cell lung cancer

      CURRENT OPINION IN ONCOLOGY
    21. Dillman, RO; DeLeon, C; Beutel, LD; Barth, NM; Schwartzberg, LS; Spitler, LE; Garfield, DH; O'Connor, AA; Nayak, SK
      Short-term autologous tumor cell lines for the active specific immunotherapy of patients with metastatic melanoma

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    22. Hori, T; Kodama, H; Nishimura, S; Hatano, T; Okamura, R; Fujii, K; Kudo, T; Inamoto, T; Sawai, K; Kobayashi, M; Ogawa, H; Yoshimura, N; Hiraoka, M
      A randomized study comparing oral and standard regimens for metastatic breast cancer

      ONCOLOGY REPORTS
    23. Adachi, S; Ogasawara, T; Ito, K; Koyama, M; Nagano, T; Suzuki, A; Yamada, T; Nakata, Y; Ozawa, M
      A pilot study of paclitaxel and carboplatin for recurrent ovarian cancer

      ONCOLOGY REPORTS
    24. Ghaneh, P; Slavin, J; Sutton, R; Hartley, M; Neoptolemos, JP
      Adjuvant therapy in pancreatic cancer

      WORLD JOURNAL OF GASTROENTEROLOGY
    25. de Jong, PC; Blankenstein, MA; van de Ven, J; Nortier, JWR; Blijham, GH; Thijssen, JHH
      Importance of focal aromatase activity in hormone-dependent breast cancer:a review

      BREAST
    26. Basser, RL
      Optimal dose of chemotherapy in adjuvant treatment of breast cancer

      BREAST
    27. Huncharek, M; Caubet, JF; McGarry, R
      Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials

      MELANOMA RESEARCH
    28. Twelves, C; Boyer, M; Findlay, M; Cassidy, J; Weitzel, C; Baker, C; Osterwalder, B; Jamieson, C; Hieke, K
      Capecitabine (Xeloda (TM)) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients withadvanced colorectal carcinoma

      EUROPEAN JOURNAL OF CANCER
    29. Eggermont, AMM
      The role interferon-alpha in malignant melanoma remains to be defined

      EUROPEAN JOURNAL OF CANCER
    30. Schellens, JHM; Planting, AST; Ma, J; Maliepaard, M; de Vos, A; Dennert, MD; Verweij, J
      Adaptive intrapatient dose escalation of cisplatin in patients with advanced head and neck cancer

      ANTI-CANCER DRUGS
    31. Aapro, M; Rowinsky, E
      Docetaxel: assessing a range of activity

      ANTI-CANCER DRUGS
    32. Oberhoff, C; Hoffmann, O; Winkler, UH; Schindler, AE
      Hemostatic effects of high-dose megestrol acetate therapy in patients withadvanced gynecological cancer

      GYNECOLOGICAL ENDOCRINOLOGY
    33. Stacul, F
      Current iodinated contrast media

      EUROPEAN RADIOLOGY
    34. Henk, JM
      Concomitant chemoradiation for head and neck cancer: Saving lives or grays?

      CLINICAL ONCOLOGY
    35. Khuri, FR; Herbst, RS; Fossella, FV
      Emerging therapies in non-small-cell lung cancer

      ANNALS OF ONCOLOGY
    36. Berghmans, T; Paesmans, M; Sculier, JP
      The role of cisplatin in the treatment of small-cell lung cancer?

      ANNALS OF ONCOLOGY
    37. Hirsch, FR; Osterlind, K; Jeppesen, N; Dombernowsky, P; Ingeberg, S; Sorensen, PG; Kristensen, C; Hansen, HH
      Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: A prospective randomised trial of 280 consecutive patients

      ANNALS OF ONCOLOGY
    38. Gridelli, C; Perrone, F; Nelli, F; Ramponi, S; De Marinis, F
      Quality of life in lung cancer patients

      ANNALS OF ONCOLOGY
    39. Hidaka, T; Fujimura, M; Sakai, M; Saito, S
      Macrophage colony-stimulating factor prevents febrile neutropenia induced by chemotherapy

      JAPANESE JOURNAL OF CANCER RESEARCH
    40. Gu, GJ; Zhang, CD
      A spectrum analysis of synoptic-scale disturbances in the ITCZ

      JOURNAL OF CLIMATE
    41. Armstrong, DK; Davidson, NE
      Dose intensity for breast cancer

      ONCOLOGY-NEW YORK
    42. Gandara, DR; Edelman, MJ; Lara, PN; Lau, DHM
      Gemcitabine in combination with new platinum compounds: An update

      ONCOLOGY-NEW YORK
    43. Johnson, DH
      Gemcitabine for the treatment of non-small-cell lung cancer

      ONCOLOGY-NEW YORK
    44. Crino, L; Calandri, C; Maestri, A; Marrocolo, F
      Gemcitabine and cisplatin combination in early-stage non-small-cell lung cancer

      ONCOLOGY-NEW YORK
    45. Rosell, R; Sanchez, JM; Taron, M; O'Brate, A; Gutierrez, JL; Monzo, M; Felip, E; Sanchez, JJ; Alberola, V
      Novel approaches in the treatment of non-small-cell lung cancer

      ONCOLOGY-NEW YORK
    46. Lamont, JP; Kuhn, JA; Nemunaitis, JJ; McCarty, TM
      Gene therapy for head and neck cancers

      ONCOLOGY-NEW YORK
    47. Thurman, SA; Ramakrishna, NR; DeWeese, TL
      Radiation therapy for the treatment of locally advanced and metastatic prostate cancer

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    48. Sause, WT
      Nonsurgical management of non-small-cell lung cancer

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    49. Todeschini, G
      High-dose anthracycline induction in adult acute lymphocytic leukemia

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    50. Bradstock, K; Matthews, J; Young, G; Lowenthal, R; Baxter, H; Arthur, C; Bashford, J; Brighton, T; Cannell, P; Dunlop, L; Durrant, S; Enno, A; Eliadis, P; Gill, D; Gillett, A; Gottlieb, D; Januszewicz, H; Joshua, D; Leahy, M; Schwarer, A; Taylor, K
      Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia

      LEUKEMIA
    51. Visani, G; Bernasconi, P; Boni, M; Castoldi, GL; Ciolli, S; Clavio, M; Cox, MC; Cuneo, A; Del Poeta, G; Dini, D; Falzetti, D; Fanin, R; Gobbi, M; Isidori, A; Leoni, F; Liso, V; Malagola, M; Martinelli, G; Mecucci, C; Piccaluga, PP; Petti, MC; Rondelli, R; Russo, D; Sessarego, M; Specchia, G; Testoni, N; Torelli, G; Mandelli, F; Tura, S
      The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia - analysis of 848 patients

      LEUKEMIA
    52. Rowe, JM
      Uncertainties in the standard care of acute myelogenous leukemia

      LEUKEMIA
    53. Turner, R; Anglin, P; Burkes, R; Couture, F; Evans, W; Goss, G; Grimshaw, R; Melosky, B; Paterson, A; Quirt, I
      Epoetin alfa in cancer patients: Evidence-based guidelines

      JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
    54. Sandblom, G; Varenhorst, E
      Incidence rate and management of prostate carcinoma

      BIOMEDICINE & PHARMACOTHERAPY
    55. Beretta, GD; Pessi, MA; Poletti, P; Mosconi, S; Labianca, R
      New drugs and combinations in the palliative treatment of colon and rectalcancer

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    56. Bennett, CL; Hynes, D; Godwin, J; Stinson, TJ; Golub, RM; Appelbaum, FR
      Economic analysis of granulocyte colony stimulating factor as adjunct therapy for older patients with acute myelogenous leukemia (AML): Estimates from a Southwest Oncology Group clinical trial

      CANCER INVESTIGATION
    57. Nabholtz, JM; Bonneterre, J; Buzdar, A; Robertson, JFR; Thurlimann, B; Steinberg, M; Webster, A; von Euler, M
      Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer? Reply

      JOURNAL OF CLINICAL ONCOLOGY
    58. Smith, IE; O'Brien, MER; Talbot, DC; Nicolson, MC; Mansi, JL; Hickish, TF; Norton, A; Ashey, S
      Duration of chemotherapy in advanced non-small-cell lung cancer: A randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin

      JOURNAL OF CLINICAL ONCOLOGY
    59. Robnett, TJ; Machtay, M; Stevenson, JP; Algazy, KM; Hahn, SM
      Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma

      JOURNAL OF CLINICAL ONCOLOGY
    60. Balducci, L; Lyman, GH
      Patients aged <= 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy

      JOURNAL OF CLINICAL ONCOLOGY
    61. Ackland, SP; Anton, A; Breitbach, GP; Colajori, E; Tursi, JM; Delfino, C; Efremidis, A; Ezzat, A; Fittipaldo, A; Kolaric, K; Lopez, M; Viaro, D
      Dose-intensive epirubicin-based chemotherapy is superior to an intensive intravenous cyclophosphamide, methotrexate, and fluorouracil regimen in metastatic breast cancer: A randomized multinational study

      JOURNAL OF CLINICAL ONCOLOGY
    62. von der Maase, H; Hayden, AM
      Gemcitabine and cisplatin for advanced, metastatic bladder cancer - In reply

      JOURNAL OF CLINICAL ONCOLOGY
    63. Goss, PE; Strasser, K
      Aromatase inhibitors in the treatment and prevention of breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    64. Fortin, A; Couture, C; Doucet, R; Albert, M; Allard, J; Tetu, B
      Does histologic grade have a role in the management of head and neck cancers?

      JOURNAL OF CLINICAL ONCOLOGY
    65. Sternberg, CN; Parmar, MKB
      Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer

      JOURNAL OF CLINICAL ONCOLOGY
    66. Sternberg, CN; Calabro, F
      Neo-adjuvant chemotherapy in invasive bladder cancer

      WORLD JOURNAL OF UROLOGY
    67. Nolte, W; Ramadori, G
      New aspects in the palliative treatment of metastatic colorectal carcinoma

      MEDIZINISCHE KLINIK
    68. Reimer, P; Ruckle-Lanz, H
      New therapeutic options in the chemotherapy of advanced colorectal cancer

      MEDIZINISCHE KLINIK
    69. Erkisi, M; Erkurt, E; Zeren, H; Tunali, C; Kocabas, A; Burgut, R
      Anticipated administration of GM-CSF in the treatment of non small cell lung cancer

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    70. Clavio, M; Quintino, S; Masoudi, B; Carrara, S; Cerri, R; Pierri, I; Canepa, L; Miglino, M; Muner, P; Damasio, E; Gobbi, M
      Cost of de novo acute myeloid leukemia induction therapy in adults: Analysis of EORTC-GIMEMA AML10 and FLANG regimens

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    71. Blackshear, PJ; Lai, WS; Thorn, JM; Kennington, EA; Staffa, NG; Moore, DT; Bouffard, GG; Beckstrom-Sternberg, SM; Touchman, JW; Bonaldo, MD; Soares, MB
      The NIEHS Xenopus maternal EST project: interim analysis of the first 13,879 ESTs from unfertilized eggs

      GENE
    72. Inoue, A; Saijo, N
      Recent advances in the chemotherapy of non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    73. Lee, ST; Jang, JH; Suh, HC; Hahn, JS; Ko, YW; Min, YH
      Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome

      AMERICAN JOURNAL OF HEMATOLOGY
    74. Curran, WJ; Ajani, J; Ang, K; Bonanni, R; Bruner, D; Byhardt, R; Eisenberg, B; Gillin, MT; Ginsberg, RJ; Greven, K; Grignon, D; Hammond, E; Layne, E; McCormick, B; Mehta, M; Michalski, J; Okunieff, P; Sandler, H; Scarantino, CW; Willett, C
      Radiation Therapy Oncology Group, research plan 2002-2006

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    75. Sim, S; Rosenzweig, KE; Schindelheim, R; Ng, KK; Leibel, SA
      Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of locally advanced non-small-cell lung cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    76. Nag, S; Cano, ER; Demanes, DJ; Puthawala, AA; Vikram, B
      The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    77. Harrington, KJ; Rowlinson-Busza, G; Syrigos, KN; Uster, PS; Vile, RG; Peters, AM; Stewart, JSW
      The effect of irradiation on the biodistribution of radiolabeled pegylatedliposomes

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    78. Jeremic, B; Shibamoto, Y; Acimovic, L; Milicic, B; Milisavljevic, S; Nikolic, N; Dagovic, A; Aleksandrovic, J; Radosavljevic-Asic, G
      Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: A randomized trial

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    79. Tyldesley, S; Boyd, C; Schulze, K; Walker, H; Mackillop, WJ
      Estimating the need for radiotherapy for lung cancer: An evidence-based, epidemiologic approach

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    80. Owen, JB; Grigsby, PW; Caldwell, TM; Konski, AA; Johnson, DJ; Demas, WF; Movsas, B; Jones, CU; Wasserman, TH
      Can costs be measured and predicted by modeling within a cooperative clinical trials group? Economic methodologic pilot studies of the Radiation Therapy Oncology Group (RTOG) studies 90-03 and 91-04

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    81. Baumann, M; Bentzen, SM; Doerr, W; Joiner, MC; Saunders, M; Tannock, IF; Thames, HD
      The translational research chain: Is it delivering the goods?

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    82. Crane, CH; Janjan, NA; Abbruzzese, JL; Curley, S; Vauthey, JN; Sawaf, HB; Dubrow, R; Allen, P; Ellis, LM; Hoff, P; Wolff, RA; Lenzi, R; Brown, TD; Lynch, P; Cleary, K; Rich, TA; Skibber, J
      Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    83. Vincent, JL; Brase, R; Santman, F; Suter, PM; McLuckie, A; Dhainaut, JF; Park, Y; Karmel, J
      A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome

      INTENSIVE CARE MEDICINE
    84. Kalden, JR; Scott, DL; Smolen, JS; Schattenkirchner, M; Rozman, B; Williams, BD; Kvien, TK; Jones, P; Williams, RB; Oed, C; Rosenburg, R
      Improved functional ability in patients with rheumatoid arthritis - Longterm treatment with leflunomide versus sulfasalazine

      JOURNAL OF RHEUMATOLOGY
    85. Hakamies-Blomqvist, L; Luoma, ML; Sjostrom, J; Pluzanska, A; Sjodin, M; Mouridsen, H; Ostenstad, B; Mjaaland, I; Ottosson, S; Bergh, J; Malmstrom, PO; Blomqvist, C
      Timing of quality of life (QoL) assessments as a source of error in oncological trials

      JOURNAL OF ADVANCED NURSING
    86. Ahn, JB; Shim, KY; Jeung, HC; Rha, SY; Yoo, NC; Kim, NK; Roh, JK; Min, JS; Kim, BS; Chung, HC
      Monthly 5-days 5-fluorouracil and low-dose leucovorin for adjuvant chemotherapy in colon cancer

      CANCER LETTERS
    87. Montemaggi, P; Trovo, M; Guerrieri, P; Cancian, L
      Clinical cases

      TUMORI
    88. Lupattelli, M; Maranzano, E; Bellavita, R; Tarducci, R; Latini, R; Castagnoli, P; Bufalari, A; Corgna, E; Pinaglia, D; Rossetti, R; Ribacchi, R; Latini, P
      Adjuvant radiochemotherapy in high-risk rectal cancer results of a prospective non-randomized study

      TUMORI
    89. Lehrnbecher, T
      Hematopoietic growth factors in the prevention of infections complicationsin children with hematologic-oncologic diseases.

      KLINISCHE PADIATRIE
    90. Tjan-Heijnen, VCG; Groen, HJM; Schramel, FMNH; Stoter, G
      Consensus conference on palliative treatment of stage IV non-small cell lung cancer - Consensus Meeting of the Netherlands Society for Medical Oncology and the Taskforce on Lung Cancer of the Dutch Society of Physicians for Lung Diseases and Tuberculosis

      NETHERLANDS JOURNAL OF MEDICINE
    91. Cabrera, J; Munoz, J; Sanchez, J
      Current trends in the treatment of locally advanced non-small cell bronchopulmonary carcinoma

      ARCHIVOS DE BRONCONEUMOLOGIA
    92. Bergh, J; Jonsson, PE; Glimelius, B; Nygren, P
      A systematic overview of chemotherapy effects in breast cancer

      ACTA ONCOLOGICA
    93. Ragnhammar, P; Hafstrom, L; Nygren, P; Glimelius, B
      A systematic overview of chemotherapy effects in colorectal cancer

      ACTA ONCOLOGICA
    94. Sorenson, S; Glimelius, B; Nygren, P
      A systematic overview of chemotherapy effects in non-small cell lung cancer

      ACTA ONCOLOGICA
    95. Macheta, M; Yin, JAL
      Recent advances in the treatment of AML

      HEMATOLOGICAL ONCOLOGY
    96. Janinis, J; Papadakou, M; Panagos, G; Panousaki, A; Georgoulias, V; Hatzidaki, D; Lefantzis, D; Dokianakis, G
      Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracilin patients with locally advanced head and neck cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    97. Kalaycio, M; Pohlman, B; Elson, P; Lichtin, A; Hussein, M; Tripp, B; Andresen, S
      Chemotherapy for acute myelogenous leukemia in the elderly with cytarabine, mitoxantrone, and granulocyte-macrophage colony-stimulating factor

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    98. Komaki, R; Chasen, MH; Travis, WD; Putnam, JB; Fossella, FV; Byhardt, RW; Ro, JY
      Oncodiagnosis panel: 1999 cancer of the lung: Oncodiagnosis

      RADIOGRAPHICS
    99. Bonig, H; Silbermann, S; Weller, S; Kirschke, R; Korholz, D; Janssen, G; Gobel, U; Nurnberger, W
      Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF) - results of a prospective randomised monocentre study

      BONE MARROW TRANSPLANTATION
    100. Falk, MH; Issels, RD
      Hyperthermia in oncology

      INTERNATIONAL JOURNAL OF HYPERTHERMIA


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 03:03:20